Elsevier Integrates New Collaboration Analysis Capabilities Into SciVal Strata to Further Enhance Research Evaluation

AMSTERDAM, July 12, 2011 -

Elsevier, a world-leading provider of scientific, technical and
medical information products and services, today announced two new
collaboration analyses capabilities available within SciVal Strata
( href="www.info.scival.com/strata">www.info.scival.com/strata),
a web-based tool focused on the evaluation of research performance.
SciVal Strata offers researchers and research administrators the
flexibility to construct relevant contextual data to benchmark
research teams or individual researchers, using a range of
indicators based on Elsevier’s Scopus data.

The collaboration analysis capabilities add a novel dimension to
SciVal Strata, enabling users to assess collaboration between
researchers. The new capabilities are:

• Geographical Collaboration Network: Enables research
  administrators and researchers to view the locations by region and
  country where a researcher or research team is or has collaborative
  links. Furthermore, it allows users to observe activity trends over
  time for any specific region or country.
• Author Network: Allows users to view the complete team
  in which researchers or research teams collaborated. Moreover, it
  indicates how often those co-authors have published with that
  individual or team displaying their prestige according to the
  h- or g-Indices, measures that represent a
  combination of productivity and citation impact.

“By empowering academic and governmental research advisors and
researchers to assess collaboration, SciVal Strata now provides a
multidimensional way to evaluate distinguished researchers and
early career researchers alike,” said Niels Weertman, Vice
President of Product Management, Scopus and SciVal. “Furthermore,
this new approach will support strategic decisions including
recruitment and partnerships, ultimately improving research
outcomes.”  

For an early career researcher who has published few articles
and has not yet gained a critical mass of citation counts (an
indicator for traditional performance analysis), geographical
collaboration and prestigious co-authors may indicate that the
researcher is viewed positively in the field and able to attract
established scientists for collaboration - all qualifications for
potential recruitment or funding applications. By providing this
novel approach to evaluating research performance, SciVal Strata
continues to enable researchers and research administrators to
identify the strengths of research teams and individual researchers
most relevant to their field of expertise, topics of interest or
career stage.

About the Elsevier SciVal^®
Suite

Elsevier’s SciVal suite
( href="www.info.scival.com">www.info.scival.com)
of services supports academic and government leadership in
evaluating, establishing and executing research strategies that
optimize the performance of existing assets and maximize
investments to enhance near and long-term productivity. SciVal
tools leverage Scopus® data, Elsevier’s trusted source of
bibliometric data, to offer innovative yet authoritative solutions.
Current suite offerings include: SciVal Spotlight™, a strategic
tool that generates unique institutional and country maps of
existing and emerging strengths based on an interdisciplinary
perspective of current performance; SciVal Funding™, an online
solution that provides targeted recommendations on grants to pursue
based on pre-populated research profiles and historical awards;
SciVal Strata, a web-based research performance tool that offers
users the flexibility to construct relevant contextual data to
evaluate research teams or individual researchers, using a range of
indicators based on Scopus data; SciVal Experts, a semantic
technology-based application that enables researchers to identify
and locate sources of expertise at an individual or departmental
level within and across institutions.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in
partnership with the global science and health communities to
publish more than 2,000 journals, including href="www.thelancet.com">The Lancet and href="www.cell.com">Cell, and close to 20,000
book titles, including major reference works from Mosby and
Saunders. Elsevier’s online solutions include href="www.sciencedirect.com/">SciVerse ScienceDirect, href="www.scopus.nl">SciVerse Scopus, href="www.reaxys.com">Reaxys, href="www.mdconsult.com">MD Consult and href="www.nursingconsult.com">Nursing Consult, which
enhance the productivity of science and health professionals, and
the SciVal suite and href="www.medai.com">MEDai’s Pinpoint Review, which help
research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, href="www.elsevier.com">Elsevier employs 7,000 people
worldwide. The company is part of href="www.reedelsevier.com">Reed Elsevier Group PLC, a
world-leading publisher and information provider, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols
are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).

Media contact
Jen Saunders/Sandra Plasse
+1-212-752-8338
jsaunders@psbpr.com
splasse@psbpr.com

.